Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS)

215 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 52,828,671 shares of 105,670,220 outstanding shares and own 50% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9,900,341 shares), STATE STREET CORP (4,904,513 shares), VANGUARD GROUP INC (4,791,244 shares), FMR LLC (4,779,269 shares), Woodline Partners LP (2,883,657 shares), Point72 Asset Management, L.P. (1,914,932 shares), DIMENSIONAL FUND ADVISORS LP (1,621,409 shares), Invus Financial Advisors, LLC (1,612,077 shares), Boxer Capital, LLC (1,602,200 shares), and AMERIPRISE FINANCIAL INC (1,201,021 shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.